For instance, the expression levels of PD-L1 and other immune checkpoint molecules in the tumor microenvironment may serve as potential biomarkers for response, but their utility in the context of bone metastases is still being explored (reviewed by Xiang et al. [139]). Here, CD274 is linked to neoplasm.